Blog

Internship Testimonial- Flexible, customized and fun!

Not too long ago, I was in the last month and a half of my final year of pharmacy school. Only a handful of clinical experiences stood between me and walking across the stage to claim the sought-after PharmD. Around this time, I remember grabbing my phone and arbitrarily flipping through a stream of nondescript notifications until one — just one — caught my attention. It read, “PharmD Class of 2026 – P4s: 2026 RxPharmacist Summer Internship Part Time Program.” I simply couldn’t resist my curiosity.

All throughout pharmacy school, I’ve wanted to work and gain experience in niche pharmacy-related spaces. Opening that email and pursuing the opportunity turned out to be truly worthwhile.

I was tasked with two main assignments — first, updating the Tennessee MPJE study guide, and second, creating social media clips to further promote RxPharmacist. Both pushed me beyond my comfort zone, and both left me with transferable skills. The primary takeaway I’ve learned is that any project can be completed by breaking it down into smaller segments, and that anyone can learn almost anything, no matter their skill level, through small, consistent efforts.

I’m grateful for my time in this role as a graduate intern, and I encourage every student and pharmacist to maintain a state of learning while enjoying and trusting the process. I had excellent support throughout, along with the opportunity to further develop my time management and self-learning skills. Moving forward, I’ll carry these lessons with me as I begin an HSPAL PGY1 & 2 residency — a next step this internship helped prepare me for.

-Jessica W., RxPharmacist Graduate Intern

Internship Testimonial- Flexible, customized and fun! Read More »

Best Free Tools and Apps Every Pharmacist Should Use

The modern pharmacist is expected to practice at the top of their license. They must make complex, evidence-based clinical decisions, be updated on rapidly evolving guidelines, counsel patients across a wide range of health conditions with limited time and often limited resources. Fortunately, the digital landscape has never offered more high-quality, free tools to support that kind of practice.

As the toolkit has grown, so has the conversation. The concern around a new addition to the clinical workflow: artificial intelligence (AI). Rapidly developing and highly invested in, AI is changing the healthcare landscape as AI-assisted tools are appearing in drug databases, literature search platforms, clinical decision support systems, and documentation software that outpaces most pharmacists’ training in how to use them critically. That conversation cannot be separated from the tools themselves. It is a pharmacist’s responsibility to differentiate what to use, but how also how to use it appropriately.

Whether you are a pharmacy student preparing for APPE rotations, a new practitioner building your daily workflow, or an experienced clinician looking to expand your resources, this post covers the free tools and apps that belong in every pharmacist’s digital toolkit.

Mobile Apps

Epocrates

Platform: iOS and Android | Cost: Free (Epocrates+ upgrade available) | Developer: Epocrates

Epocrates is a widely used clinical reference app among pharmacists and physicians. The free version includes:

  • Drug information
  • Interaction checker
  • Pill ID
  • Guidelines and decision tools
  • Medical news
  • Calculators and risk scores
  • Reference tables
  • “Bugs and Drugs” infectious disease reference

This provides a substantial amount of features at no cost. There is a paid Epocrates+ tier that unlocks disease information, herbs and supplements, ICD-10 codes, infectious disease treatment guidelines, and lab references. For pharmacists, the free tier covers core clinical functions. Students on APPE rotations and new practitioners could start with the free version and assess whether the additional content justifies the cost based on their practice setting. Some users report that ads remain present even in the paid version, which is worth knowing before upgrading.


Pyrls

Platform: iOS and Android | Cost: Free (Pyrls Pro upgrade available) | Developer: Cosmas Health, Inc.

Pyrls is a free clinical reference app built by pharmacists, for pharmacists. The free version includes:

  • Medication naming, indications, and pharmacology
  • Counseling points and clinical pearls related to place in therapy, safety, and monitoring for each medication
  • Reference tables, figures, and charts

The content is presented in a clean format designed for quick look up during a busy shift or rotation rather than extended reading. Pyrls emphasizes high-yield clinical pearls, especially the practical, nuanced details that experienced pharmacists know intuitively but can be difficult to find when digging through standard drug databases. User reviews highlight that the content is particularly useful for refreshing learned information on top medications and their counseling points. Also, users praise how the app continues to add guideline summaries and clinical charts over time. The free tier provides access to core drug content covering the medications pharmacists encounter most frequently and is sufficient for most daily clinical questions. Pyrls Pro expands access to a broader drug library and additional clinical content for practitioners whose practice demands it.


CDC Vaccine Schedules App

Platform: iOS and Android | Cost: Free | Developer: CDC

The CDC Vaccine Schedules app is the official mobile version of the recommended immunization schedules published by the Advisory Committee on Immunization Practices (ACIP). It covers the childhood, adolescent, and adult immunization schedules in a clean, navigable format and is updated whenever ACIP releases schedule revisions. The app allows pharmacists to quickly look up the recommended schedule for a specific vaccine, review catch-up immunization guidance for patients who are behind, check contraindications and precautions for each vaccine, and walk through the full immunization schedule when conducting a vaccine review. Particularly for community pharmacists and ambulatory care practitioners, this app is essential. Vaccine administration and counseling is now a core pharmacist function and having ACIP recommendations at your fingertips ensures that what you are telling patients reflects the most current evidence and guidance.


CDC STI Treatment Guidelines App

Platform: iOS and Android | Cost: Free | Developer: CDC

The CDC STI Treatment Guidelines app has the full CDC Sexually Transmitted Infections Treatment Guidelines directly on your phone in a searchable, user-friendly format. These guidelines are the authoritative clinical reference for the diagnosis, treatment, and management of sexually transmitted infections in the United States published by the CDC.

The app covers treatment regimens for gonorrhea, chlamydia, syphilis, genital herpes, HPV, trichomoniasis, pelvic inflammatory disease, and more. It provides first-line and alternative regimens, medication dosing, treatment duration, special population considerations (pregnancy, HIV-positive patients, pediatric patients), and counseling recommendations. It also includes guidance on partner notification and management, which is increasingly relevant given how often STI-related questions come up at the pharmacy counter, within the clinic, and in the emergency department. Pharmacists who can quickly pull up current CDC treatment guidance are better equipped to counsel patients, verify antibiotic regimens prescribed by other providers, and identify outdated or suboptimal therapy. This is particularly important as STI resistance patterns continue to evolve.


CDC Contraception App (Contraceptive Guidance for Health Care Providers)

Platform: iOS and Android | Cost: Free | Developer: CDC

The CDC Contraception app is the mobile version of the U.S. Medical Eligibility Criteria for Contraceptive Use (US MEC) and the U.S. Selected Practice Recommendations for Contraceptive Use (US SPR), which are the two CDC frameworks that form the clinical foundation for evidence-based contraceptive counseling in the United States. The app allows users to input a patient’s medical conditions and receive a structured summary on which contraceptive methods are safe, should be used with caution, or contraindicated based on the patient’s individual clinical profile. Categories range from MEC 1 (no restriction) to MEC 4 (absolute contraindication). The guidance is evidence-based, regularly updated, and specific enough to be directly applicable in clinical practice.

Pharmacists are increasingly involved in contraceptive counseling through medication therapy management visits, patient counseling at the point of dispensing, or collaborative practice agreements with OB/GYN providers. The CDC Contraception app transforms what could be a knowledge-intensive, potentially error-prone conversation into a structured, evidence-based consultation that serves patients and protects practitioners.


About Herbs App

Platform: iOS and Android | Cost: Free | Developer: Memorial Sloan Kettering Cancer Center

The About Herbs app is a clinically rigorous, free resource available for dietary supplement and herbal medicine information. Developed and maintained by Memorial Sloan Kettering Cancer Center’s Integrative Medicine Service, About Herbs provides evidence-based monographs on hundreds of herbs, vitamins, minerals, botanical supplements, and other natural products.

Each monograph includes information on common uses, clinical evidence supporting or refuting those claims and specific considerations for cancer patients. It also contains basic pharmaceutical information such as known adverse effects, drug interactions, contraindications, The content is regularly reviewed by pharmacists, physicians, and researchers while the evidence is graded by quality. The quality grading distinguishes between findings from well-designed clinical trials and those based on preclinical data or anecdotes. Since patients routinely take dietary supplements alongside prescription medications, this app is most prudent for pharmacists as a tool to properly counsel. Many common herbs have clinically meaningful interactions with drugs pharmacists dispense every day. Some examples include St. John’s Wort and CYP3A4 substrates, fish oil and anticoagulants, echinacea and immunosuppressants, garlic and antiplatelet agents. For pharmacists with oncology patients, the cancer-specific data in About Herbs is particularly valuable, as this population often pursues integrative therapies alongside chemotherapy without always discussing it with their oncology team.


MDCalc

Platform: iOS and Android | Cost: Free | Developer: MD Aware, LLC

MDCalc is a widely used free clinical calculator platform in pharmacy and medicine. It contains hundreds of validated clinical scoring tools and calculators. Each is accompanied by a description of the underlying study, the original derivation population, and notes on clinical interpretation. Pharmacists use MDCalc for tools like the Cockcroft-Gault equation for creatinine clearance, the CHA₂DS₂-VASc score for anticoagulation decisions in atrial fibrillation, the HAS-BLED score for bleeding risk, the Wells Criteria for DVT and PE, and many others. What makes MDCalc particularly valuable is that it links each calculator directly to the original validation study, giving pharmacists context about when the tool is and is not appropriate to apply. For instance, creatinine clearance estimate may need to be interpreted differently in a patient with very low muscle mass, very advanced age, or extreme body weight. MDCalc’s evidence summaries help pharmacists think through those nuances rather than applying a number mechanically.


Drugs.com

Platform: iOS and Android | Cost: Free | Developer: Drugs.com

The Drugs.com interaction checker is one of the most accessible free tools for multi-drug interaction screening. It allows users to input an entire medication list and quickly survey interactions categorized by severity. While Drugs.com is not a substitute for clinical drug databases like Lexicomp or Micromedex (which are subscription-based), it is a practical and reasonably comprehensive free option for students on rotation and pharmacists in resource-limited settings. An important caveat for usage—interaction severity classifications vary across databases, and what one database flags as a major interaction may be categorized differently in another. The best practice is to use free tools as a starting point and verify clinically significant interactions against primary literature or an authoritative secondary database to further assess the clinical implications of the interaction.

Websites

DailyMed

Cost: Free | Developer: National Institutes of Health

The National Library of Medicine DailyMed platform provide free access to the complete, manufacturer-submitted prescribing information (package inserts) for every FDA-approved drug in the United States. DailyMed is particularly valuable because it is updated in real time when manufacturers revise labeling. This means it reflects the most current safety information, black box warnings, dosing guidance, and approved indications available. For any clinical question about what is officially approved, DailyMed is the authoritative primary source.

DailyMed is especially important when evaluating off-label use, verifying pregnancy and lactation categories, or checking specific pharmacokinetic parameters. Using it alongside a clinical drug database creates a more complete picture than either source alone.


LiverTox

Cost: Free | Developer: National Institutes of Health

Drug-induced liver injury is a commonly known risk with acetaminophen usage, but the risk of hepatotoxicity with other drugs may not be as easy to ascertain. LiverTox serves as a resource to quickly find information related to liver injury that is associated with many drugs on the market. This includes background on how the drug causes liver injury, a “Likelihood Score” for the drug causing liver injury, and how to approach a patient that presents with drug-induced liver injury.


LactMed

Cost: Free | Developer: National Institutes of Health

LactMed is a peer-reviewed database specifically focused on the safety of medications and chemicals during breastfeeding, including information on drug levels in breast milk, potential infant effects, and alternative options. This resource fills a gap that general drug databases frequently handle poorly. Questions about medication safety during pregnancy arise daily in practice, and pharmacists equipped with these specialized tools are better positioned to give accurate, individualized guidance.


MotherToBaby

Cost: Free | Developer: The Organization of Teratology Information Specialists

MotherToBaby provides evidence-based fact sheets on medication safety during pregnancy and lactation, written for both clinicians and patients. This resource is extremely important because many mothers are aware that what they consume can be transferred to their baby, but they are unsure exactly what they should and should not do. Since MotherToBaby is a more patient-friendly website than other resources, the information can be directly shared with families.


GlobalRPh

Cost: Free | Developer: David McAuley, PharmD

GlobalRPh is a free, pharmacist-developed web platform that hosts a wide range of pharmacy-specific calculators including renal and hepatic dose adjustment guidance, pharmacokinetics calculators (for vancomycin and aminoglycosides), IV compatibility tools, and nutrition-related calculators. Similarly to Drugs.com, GlobalRPh is not a substitute for clinical drug databases. A prudent pharmacist should use their clinical expertise when utilizing the information and verify with a second resource as appropriate.

AI Tools in Pharmacy Practice: Powerful, but Not What You Think

No conversation about clinical tools for pharmacists in 2026 is complete without addressing artificial intelligence. This section is not a list of AI apps to download. It is a framework for using AI tools that are already in your workflow with the clinical rigor and ethical awareness your patients deserve.

AI language models can process and synthesize large volumes of text almost instantaneously. They can draft patient education materials, assist with documentation, summarize broad topic areas, suggest differentials, and generate first-pass responses to drug information questions in seconds. AI tools can reduce cognitive load meaningfully in tasks demanding breadth and speed such as overview summaries, writing assistance, and initial literature orientation. However, for clinical utilization, that value is lost. Current AI language models hallucinate, meaning they generate confident, yet incorrect clinical information. They can cite studies that do not exist, misquote studies that do, report incorrect doses, invent contraindications, and describe drug interactions that have no basis in the literature. This is a known, documented, and persistent limitation of the technology. For example, a language learning model (LLM) could claim that atorvastatin is scientifically proven to be therapeutically superior to rosuvastatin, yet no clinical study actually exists to support this claim. Another example is if an LLM says the IDSA Guidelines for Acne recommend cephalexin as first-line management of acne vulgaris, when the IDSA does not even have published guidelines for acne treatment. If a pharmacist or any other health care provider acts on an AI-generated drug interaction, dose recommendation, or guideline summary without cross-checking against a verified source, patient safety could be risked.

Bias in AI

Clinical AI tools inherit the biases present in the data they were trained on. Medical literature has historically underrepresented women, elderly patients, patients with multiple comorbidities, and racial and ethnic minority populations in clinical trial designs. AI models trained on this literature will reflect and can amplify those gaps. A dose recommendation or risk stratification generated by an AI tool may not account for pharmacogenomic variation, population-specific pharmacokinetic differences, or clinical nuances that are relevant to underrepresented groups. For example, when prompted to make a dose conversion from tacrolimus immediate-release to tacrolimus extended-release, an LLM may suggest to decrease the total daily dose of tacrolimus IR by 20% and use that as the starting dose for tacrolimus ER based on the package insert. However, the patient’s African-American ethnicity was not added to the prompt, so the LLM did not account for the fact that African-American patients are typically started at a higher tacrolimus extended-release dose due to common variations in CYP3A5 metabolism amongst ethnic groups.

Pharmacists are trained to individualize therapy and think about renal function, hepatic status, body composition, drug interactions, genetic background, and social context for each patient. That training must be applied when evaluating AI-generated clinical output. Since the AI tool cannot support that level of individualization, the pharmacist’s clinical judgment must fill the gap.

An Ethical Framework for Using AI in Practice

As professional guidance from organizations including ASHP continues to develop, a practical ethical framework for pharmacists using AI tools includes four principles to keep in mind:

  • Transparency: Be clear to colleagues, preceptors, patients, and institutions when AI tools have contributed to a clinical recommendation or documentation product, particularly in settings where that disclosure is relevant to accountability or patient trust.
  • Verification: Treat AI-generated clinical content as a hypothesis to be confirmed rather than a conclusion to be acted upon. Every dose, interaction, guideline recommendation, or clinical fact generated by AI should be verified against an authoritative source before it influences a decision affecting patient care. A trustworthy source can include a validated drug database, primary literature source, or current clinical guideline
  • Equity: Actively consider whether an AI-assisted recommendation is appropriate for the individual patient in front of you, especially when looking at patients from populations that may be poorly represented in the tool’s training data.
  • Professional Accountability: Accept that no AI tool can bear responsibility for a clinical error. The pharmacist is ultimately held responsible for decisions that are made. The license belongs to you, not the algorithm.

The most important thing to understand about AI in pharmacy practice is that it amplifies the clinical foundation of the user. A pharmacist with strong evidence-based skills and a habit of verifying information can use AI tools safely and productively. A pharmacist who substitutes AI output for clinical reasoning is on the brink of a serious error. There is currently a lack of court cases and statutory guidance to determine how medical malpractice involving inappropriate AI use should be addressed from a legal standpoint. However, every attempt should be made to avoid harming a patient, whether that be due to not validating an AI response or other means.

The Big Picture

The best digital toolkit a pharmacist can build is one that prioritizes verified, evidence-based information above speed and convenience. Free tools make high-quality clinical references more accessible than ever, but access to information is not the same as the ability to critically evaluate it. That skill belongs to the pharmacist. As AI tools become more deeply integrated into pharmacy practice, the profession will need pharmacists who can use them efficiently without delegating clinical judgment to an algorithm. The pharmacists who do this best are the ones grounded in evidence-based practice, attuned to patient individuality, and committed to the ethical responsibilities that come with the license. Download the apps, bookmark the databases, and use the calculators, but always bring your clinical brain to what the tools produce.

-APPE Student, Mollie Walters

References

  1. Epocrates. Free Clinical Decision Support App. Accessed June 29, 2026. https://www.epocrates.com/discover
  2. Cosmas Health Inc. Pyrls: Drug Information for Modern Clinical Practice. Accessed June 29, 2026. https://pyrls.com
  3. Centers for Disease Control and Prevention. CDC Vaccine Schedules App. Accessed June 29, 2026. https://www.cdc.gov/vaccines/hcp/imz-schedules/app.html
  4. Centers for Disease Control and Prevention. CDC STI Treatment Guidelines App. Accessed June 29, 2026. https://www.cdc.gov/std/treatment-guidelines/provider-resources.htm#MobileApp
  5. Centers for Disease Control and Prevention. Contraceptive Guidance for Health Care Providers App (U.S. MEC/U.S. SPR). Accessed June 29, 2026. https://www.cdc.gov/contraception/hcp/contraceptive-guidance/app.html
  6. Memorial Sloan Kettering Cancer Center. About Herbs, Botanicals & Other Products. Accessed June 29, 2026. https://www.mskcc.org/cancer-care/diagnosis-treatment/symptom-management/integrative-medicine/herbs/search
  7. National Library of Medicine. DailyMed: Current Prescribing Information. Accessed June 29, 2026. https://dailymed.nlm.nih.gov
  8. National Institute of Diabetes and Digestive and Kidney Diseases. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. Updated May 6, 2026. Accessed July 3, 2026. https://www.ncbi.nlm.nih.gov/books/NBK547852/
  9. National Institute of Child Health and Human Development. Drugs and Lactation Database (LactMed®). National Library of Medicine. Accessed June 29, 2026. https://www.ncbi.nlm.nih.gov/books/NBK501922/
  10. MotherToBaby. Evidence-Based Information for Pregnant and Breastfeeding Patients. Accessed June 29, 2026. https://mothertobaby.org/our-work/
  11. MDCalc. About MDCalc. Accessed June 29, 2026. https://www.mdcalc.com/about-us
  12. Schutz N, Kalichira AL, Worthy Woodbury CDRK, et al. ASHP statement on the use of artificial intelligence in pharmacy. Am J Health Syst Pharm. 2020;77(23):2015-2018. doi:10.1093/ajhp/zxaa249
  13. Obermeyer Z, Powers B, Vogeli C, Mullainathan S. Dissecting racial bias in an algorithm used to manage the health of populations. Science. 2019;366(6464):447-453. doi:10.1126/science.aax2342
  14. Veloxis Pharmaceuticals Inc. Envarsus XR (tacrolimus extended-release tablets) [package insert]. Revised December 2018. Accessed July 1, 2026. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206406s007lbl.pdf

Best Free Tools and Apps Every Pharmacist Should Use Read More »

How to Excel on Advanced Pharmacy Practice Experience Rotations

Advanced Pharmacy Practice Experience (APPE) rotations are a defining chapter of pharmacy school. After years of classroom lectures, pharmacokinetics equations, and drug interaction tables, APPE is where everything finally comes together in real time. Whether you are joining an inpatient pharmacy team, rounding in the ICU, or seeing patients in an ambulatory care clinic, the expectations are greatly increased in comparison to Introductory Pharmacy Practice Experience (IPPE) rotations. Preceptors are not looking for students who can recite a mechanism of action. They want students who can think, apply, and communicate like a pharmacist. APPEs serve as the bridge between a student that needs supervised and a pharmacist that performs the supervising. For this reason, preceptors want to ensure that their students are prepared for making real decisions in real scenarios.

The transition to an APPE rotation can feel overwhelming at first. Most students enter their first APPE rotation unsure of how to present a patient, what to look for on morning rounds, or how to structure a Subjective, Objective, Assessment, and Plan (SOAP) note that succinctly yet sufficiently provides information. The good news is that excelling throughout your APPEs is attainable, and this post will provide guidance on creating patient case workups, topic discussions, and SOAP notes that will impress your preceptor.

The Art of the Patient Case Work-Up

One of the most important experiences you will have on clinical rotations is discussing a patient case with your preceptor. Patient case presentation is a cornerstone of learning, especially during internal medicine and critical care APPEs. This is not simply reading the chart and summarizing what the nurse or provider documented. A pharmacy student workup is an active, clinical analysis of everything happening with a patient, filtered through the lens of pharmacotherapy.

  • Where to Start: Begin with the admission diagnosis and the reason the patient is in the hospital. Then, review the medical history, surgical history, allergies, home medications, and any active problems. Pay particular attention to any comorbidities or lifestyle choices that could complicate treatment options. This background establishes the context necessary to understand where the patient came from before you can make meaningful recommendations. For example, if a patient with a complicated UTI has a documented sulfa allergy, it would not be wise to consider sulfamethoxazole-trimethoprim for this patient.
  • Review the Medication List Critically: Instead of simply copying down the medication list, dissect it. For every drug, ask yourself:
    • What is the indication?
    • Is the dose appropriate for this patient’s renal and hepatic function?
    • Are there any drug interactions with other medications on the list?
    • Is the duration appropriate?
    • Does the route of administration make sense given the patient’s current clinical status?
    • Are there any medications from home that were inappropriately continued or held?

Since a prudent pharmacist would be looking at the medication list with this level of evaluation, preceptors are expecting their student to do the same. This gives students the opportunity to practice with their guidance before they are on their own after graduation.

  • Labs, Vitals, and Trends: After the medication list has been evaluated, move to the labs and vitals of the current admission. Pay attention to trends, not just single values. A creatinine of 1.8 mg/dL looks different in a patient whose baseline is 0.9 mg/dL versus one whose baseline is 1.6 mg/dL. Look at inflammatory markers and white blood cell counts if infection is in the differential. Review cultures and sensitivities to assess whether empiric antibiotic therapy needs to be de-escalated and/or is appropriate. Evaluate glucose trends if the patient is on insulin or high-dose corticosteroids. Think about electrolytes in the context of the patient’s medications. For example, could the patient’s hypokalemia be due to furosemide use? Here is a list of reference ranges for common lab values that may be useful when reviewing a patient’s chart:
Lab ValueStandard RangeLab ValueStandard Range
Sodium136-142 mEq/LAST10-30 U/L
Potassium3.5-5.0 mEq/LALT10-40 U/L
Calcium (total)8.2-10.2 mg/dLHemoglobin12-18 g/dL
Magnesium1.3-2.1 mEq/LPlatelet count150-350*103 cells/mm3
Glucose (fasting)70-110 mg/dLWBC4.5-11.0*103 cells/mm3
Serum creatinine0.6-1.2 mg/dLBUN8-23 mg/dL
  • Building Your Assessment: Once you have gathered the data, synthesize it. What is the patient’s active problem list from a pharmaceutical standpoint? What is optimized, what needs to change, and what needs monitoring? Be prepared to provide at least one concrete recommendation for each active problem. This could include adding a specific drug (with dose, route, and frequency) to the current or home medication list. It could also include changing a current drug to an alternative agent or discontinuing a current drug altogether. If an active problem does not require any medication changes, provide a lab value that should be monitored in relation to the active problem. Your preceptor does not expect you to know everything, but they do expect you to show that you thought critically about the patient in multiple capacities.

Mastering the Topic Discussion

Topic discussions (sometimes called pharmacotherapy discussions, drug information sessions, or topic presentations) are a standard expectation on nearly every APPE rotation. These are structured, educational conversations where the student is given a relevant topic, researches it thoroughly, and presents the information to the preceptor or team.

  • Choosing a Topic: The best topic discussions arise naturally from a patient encounter. If you admitted a patient with community-acquired pneumonia (CAP) and had a question about the role of respiratory fluoroquinolones versus beta-lactam/macrolide combination therapy, that would be a suitable topic. If a recent patient in the anticoagulation clinic asks about the differences between rivaroxaban and apixaban for atrial fibrillation, That may be considered as a topic. Tying the discussion to a real patient not only makes the content more relevant, but it demonstrates clinical curiosity.
  • Structuring Your Preparation and Research: A strong topic discussion is not merely a web-browser summary. Topic discussion should be based on primary literature and current clinical guidelines. Start with the most recent guidelines from relevant professional organization (ACC/AHA for cardiology topics, IDSA for infectious disease, ADA for diabetes, etc.). Understand the guideline recommendations and the evidence provided that led to the recommendations. Then, look into one or two key clinical trials that relates to the topic and be able to discuss the study population, primary outcome, results, and clinical implications.
  • Format and Delivery: Topic discussions do not need to be formal slideshow presentations unless your preceptor requires it. In many cases, a concise verbal summary with supporting notes or a one-page reference is appropriate. Aim for clarity over comprehensiveness. A 10-minute discussion that covers the key points clearly and invites dialogue is more impressive than a 30-minute monologue that feels like the student is reading off a script.
  • Responding to Questions: Be prepared to answer follow-up questions. Preceptors will probe your understanding by asking about subpopulations, contraindications, cost considerations, medication adverse effects, or patient counseling points. If you cannot answer something, it is completely acceptable to say: “I am not sure, but I will look that up and follow up with you.” Intellectual honesty is respected far more than simply guessing.

Writing a Pharmacy SOAP Note

A well-crafted SOAP note is a clinical communication tool that showcases your reasoning when providing recommendations. Learning to write one well is a skill that will carry you through APPEs, residency, and beyond. Here is how to approach each section:

  • Subjective (S)
    • The subjective section captures information from the patient’s perspective such as what they report, how they feel, and what brought them to seek care. This includes the chief complaint, history of present illness (HPI), relevant social and family history, and current medications. It may also include relevant patient-reported symptoms such as pain level, nausea, shortness of breath, or adherence concerns. A common mistake pharmacy students make in the subjective section is providing too much or too little information. You do not need to recite the patient’s entire history, only what is relevant to the problems you are addressing. If you are writing a SOAP note for a patient presenting with uncontrolled hypertension, the relevant subjective data includes their blood pressure readings at home, their adherence to current antihypertensives, their diet and sodium intake, and their current symptoms (if any). Their history of an appendectomy in 1999 would not be appropriate to include in this SOAP note.
  • Objective (O)
    • The objective section contains measurable, verifiable clinical data. This includes the patient’s past medical and surgical history, current home medications, vital signs, laboratory values, relevant diagnostic findings (ECG, imaging results, culture data), current inpatient medication doses and routes, and physical exam findings relevant to the problem being addressed. For pharmacy-specific SOAP notes, the objective section often becomes particularly rich because medication-related data is central to the assessment. Renal function values (SCr, CrCl, eGFR), hepatic function markers (AST/ALT), drug levels if applicable (vancomycin troughs, digoxin levels, lithium concentrations), and key lab parameters that monitor efficacy or toxicity should also be included. Keep the objective section factual and organized. This is not the place for interpretations, just providing information.
  • Assessment (A)
    • This is the most intellectually demanding section of the SOAP note, and it is the one that most reveals your level of clinical thinking. The assessment is where you interpret the data and identify the drug therapy problems (DTPs) present for the patient. Organize your assessment by problem. For each active problem, state whether the condition is controlled or uncontrolled, staging of the condition (if applicable), identify any medication-related issues (subtherapeutic dosing, adverse effects, drug interactions, inappropriate therapy, unnecessary medications, need for additional therapy), and connect the objective data to support your conclusion. Proper citations should be included throughout the assessment to provide evidence-based clinical reasoning that explains how you analyzed the patient and came to your conclusions. For example, if a patient with diagnosed HFrEF is not currently receiving an SGLT2 inhibitor, you could state, “The 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure recommends patients with stage C HFrEF receive an SGLT2i to reduce heart failure-related hospitalizations” to provide concrete reasoning into why you recommended the patient be prescribed empagliflozin. The provider or preceptor appreciate and expect your recommendations to have primary sources present.
  • Plan (P)
    • The plan translates your assessment into specific, actionable recommendations. Every drug therapy problem identified in the assessment should have a corresponding plan. A well-written plan includes the specific intervention (with drug name, dose, route, frequency, and duration), monitoring parameters (symptoms to watch for, lab values to look at, what target you are aiming for, and how often to re-check), and patient counseling points. Using the HFrEF example above, the plan might read: “Recommend initiating empagliflozin 10 mg by mouth once daily. Monitor renal function (SCr, BUN) and electrolytes (Na, K, Cl, Mg) every 3 months, signs of euglycemic DKA, and counsel patient on signs of UTI (dysuria, hematuria, polyuria, urinary urgency).” This level of specificity is necessary to practice because it reflects how real clinical pharmacists think and document in their daily practice.

Habits of Successful APPE Students

Beyond the three core projects described above, students who truly stand out on APPEs share a few habits that are worth highlighting.

  • Be proactive, not reactive: Do not wait for your preceptor to ask you to look something up. Come to each interaction with questions already formulated and answers already researched. Find the drug-related problems before they are pointed out to you.
  • Own your mistakes and learn from feedback: You will make errors in judgment during your APPEs, but this is expected and part of learning. What matters is how you respond. Preceptors notice students who internalize feedback, adjust, and improve. The ability to accept constructive criticism and grow from it is a transferable skill that can be beneficial in your future career.
  • Communicate with confidence, not arrogance. When presenting a patient or making a recommendation, be clear and direct. State what you found, what you think it means, and what you recommend. You are not expected to know the correct recommendation for every situation but avoid presenting all your points with hesitation.
  • Build relationships with the team. Pharmacy students who take time to understand the workflow of the nurses, physicians, and other health professionals they work alongside are consistently rated higher by preceptors. Interprofessional collaboration is not a buzzword. It is daily clinical practice that is utilized in nearly every pharmacist’s career.

The Big Picture

Every patient case you work up, every topic discussion you prepare, and every SOAP note you write is building the clinical foundation that will define your practice as a pharmacist. If you ever feel stuck, be bold enough to ask questions. Every pharmacist knows what it’s like to be a student. This is your opportunity to demonstrate and observe the implementation of what you have learned from pharmacy in clinical practice. Put your best foot forward in your rotation to not only impress your preceptor, but to take advantage of your opportunity to learn and grow. The students who come out of APPEs ready for residency, fellowship, or entry-level practice are the ones who approached each rotation as an active learner rather than a passive observer. The skills covered in this post are the same skills that preceptors evaluate, residency programs reward, and employers expect. Start building these skills now, refine them on every rotation, and utilize them when you become a full-fledged pharmacist.

-APPE Student, Mollie Walters

References

  1. American Society of Health-System Pharmacists. Emergency medicine APPE student rotation. Accessed June 29, 2026. https://www.ashp.org/-/media/assets/pharmacy-practice/resource-centers/preceptor-toolkit/sicp-emergency-appe-student-rotation-updated.pdf
  2. Podder V, Lew V, Ghassemzadeh S. SOAP Notes. In: StatPearls. StatPearls Publishing; updated August 28, 2023. Accessed June 29, 2026. https://www.ncbi.nlm.nih.gov/books/NBK482263/
  3. Stamm PL, Haines ST, Edwards KL, et al. Educational outcomes necessary to enter pharmacy residency training: 2023 update. J Am Coll Clin Pharm. 2024;7(9):952-956. doi:10.1002/jac5.1994
  4. Stowers L. Early APPE advice. Transitions. American Pharmacists Association. Published September 18, 2018. Accessed June 29, 2026. https://www.pharmacist.com/Publications/Transitions/early-appe-advice
  5. American Society of Health-System Pharmacists. Tips and tricks for APPEs and internships – A perspective of our own. ASHP Podcasts: Student Perspectives. Published May 16, 2025. Accessed June 29, 2026. https://www.ashp.org/professional-development/ashp-podcasts/student-perspectives/2025/tips-and-tricks-for-appes-and-internships-a-perspective-of-our-own
  6. American College of Clinical Pharmacy. Reference values for common laboratory tests. Pharmacotherapy Self-Assessment Program (PSAP). Published May 2026. Accessed July 1, 2026. https://www.accp.com/docs/sap/Lab_Values_Table_PSAP.pdf

How to Excel on Advanced Pharmacy Practice Experience Rotations Read More »

Pharmacy Career Paths You Didn’t Learn About in School

Ask a pharmacy student what they plan to do after graduation and you will likely hear one of these answers: retail or residency. While there is absolutely nothing wrong with either of those paths, the reality is that a PharmD degree opens far more doors than most pharmacy programs ever stop to discuss. The job market has evolved significantly over the past decade, and pharmacists are now practicing in settings that did not exist when today’s professors were in school themselves. This is not a post about settling for something unconventional because traditional jobs are hard to find. This is about recognizing the full value of a PharmD and the remarkable range of opportunities that are actively looking for pharmacists with clinical knowledge, regulatory expertise, and communication skills. Whether you are a PY1 just beginning to think about the future or a PY4 weighing your options with graduation around the corner, this overview is designed to give you a more complete picture of what is available and how to position yourself to get there.

Traditional Career Paths

Before diving into non-traditional roles, it is worth revisiting the familiar paths because it is important to appreciate the depth of specialization and career growth available within them.

  • Community and Retail Pharmacy: Community pharmacy remains the most visible entry point into the profession. Pharmacists in this setting interact with more patients on a daily basis than almost any other healthcare provider. However, the retail landscape is shifting from simply dispensing prescriptions. Independent pharmacies and regional chains are increasingly offering clinical services such as medication therapy management (MTM), point-of-care testing, immunizations, and collaborative practice agreements with prescribers. Pharmacists who utilize their position as clinical community practitioners are creating meaningful, patient-centered interactions that look very different from the drive-through image that is often associated with the profession. If community pharmacy is your path, think about what certifications (diabetes educator, immunizer, MTM specialist) and clinical services you can build into your practice over time.
  • Health System and Hospital Pharmacy: Hospital pharmacy encompasses a spectrum of roles from general staff pharmacists to highly specialized clinical pharmacists in areas such as critical care, infectious disease, oncology, cardiology, and transplant. Many health system positions now require or strongly prefer post-graduate training, especially residency. However, entry-level positions in health systems remain available and are an excellent launching point for pharmacists who want clinical depth and interprofessional collaboration built into their daily work. Pharmacists practicing in hospital settings can perform a variety of tasks such as verify orders, round with care teams, counsel patients at discharge, and serve on pharmacy and therapeutics (P&T) committees. For students drawn to patient care in an acute setting, this is a traditional path worth pursuing. Nowadays, it often requires a residency.
  • Ambulatory Care Pharmacy: Ambulatory care sits at the intersection of community and clinical pharmacy. It is one of the fastest-growing practice areas in the profession as the expanded scope of practice allows pharmacists to serve more patients in a clinical setting. Pharmacists in ambulatory care clinics manage chronic disease states (diabetes, hypertension, hyperlipidemia, anticoagulation, heart failure) often under collaborative practice agreements that give them prescribing authority within defined protocols. Ambulatory care pharmacist positions are found in physician offices, federally qualified health centers (FQHCs), health system outpatient clinics, and patient-centered medical homes (PCMHs). A residency is recommended, if not required, to pursue this route.

Non-Traditional Career Paths

Maybe the traditional options described above do not seem to align perfectly with your interests. Maybe you are already working in a traditional setting and are ready for a change. Maybe you are tired of hearing about the same opportunities and want to know what else is available. Whatever the reason, rest assured that there are plenty of career paths opportunities for pharmacists.

  • Pharmaceutical Industry (Medical Affairs, Clinical Development, and Drug Safety): The pharmaceutical industry employs pharmacists across a wide range of functions, and it is a world that many pharmacy students may not even be aware of as options. Many pharmacist roles in industry are deeply clinical, but they focus on drug development and evidence generation rather than individual patients.
    • Medical Affairs: Pharmacists serve as scientific liaisons between a pharmaceutical company and the healthcare community. They educate physicians, nurses, and other health care providers on the clinical evidence behind a company’s medications. Medical Science Liaisons (MSLs) provide transparent, scientific information throughout the entire life cycle of a drug. This can involve assisting investigator-initiated trials or helping implement a drug in a newly approved population. This role requires strong communication skills, strong understanding with primary literature, and the ability to translate complex science for a variety of audiences.
    • Clinical Development: Pharmacists work on clinical trial teams, helping design protocols, assess drug safety, interpret clinical data, and support regulatory submissions. A background in pharmacokinetics, pharmacodynamics, and evidence-based medicine makes pharmacists particularly well-suited for this work.
    • Drug Safety and Pharmacovigilance: This is an area where pharmacists identify, analyze, and report adverse drug events from post-market surveillance. It is detailed, systematic work that directly impacts public health, and pharmacist knowledge of drug mechanisms and adverse effect profiles is a significant asset in this setting.
  • Regulatory Affairs: Pharmacists who enjoy policy, precision, and the intersection of science and law may find regulatory affairs to be an ideal fit. Pharmacists in regulatory affairs work for pharmaceutical companies, contract research organizations (CROs), or the FDA itself. They ensure that drug products meet the safety, efficacy, and quality standards required for approval and continued market authorization. The FDA employs pharmacists as reviewers, inspectors, and policy advisors across multiple centers including the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation and Research (CBER). These positions offer the opportunity to shape drug approval decisions that affect millions of patients.
  • Managed Care and Health Insurance: Managed care pharmacy is a field that has profound influence over which medications patients can access and at what cost. Pharmacists in managed care work for health insurance plans, pharmacy benefit managers (PBMs), and integrated health systems in roles focused on formulary development, utilization management, outcomes research, and drug policy. In these positions, pharmacists analyze clinical evidence, evaluate cost-effectiveness, write clinical criteria for prior authorizations, and influence coverage decisions for entire patient populations. For students interested in healthcare economics, drug policy, and systems-level thinking, managed care is a practice area that offers both intellectual depth and real-world impact.
  • Informatics and Digital Health: Health informatics is an emerging and rapidly expanding area for pharmacists, particularly as electronic health records (EHRs), clinical decision support systems, and data analytics become central to healthcare delivery. Pharmacy informatics specialists design and optimize medication-related components of EHRs, develop clinical decision support alerts, evaluate drug database systems, and analyze medication utilization data. Beyond traditional informatics roles, pharmacists are now entering digital health companies developing medication adherence platforms, telehealth services, remote patient monitoring programs, and AI-driven clinical tools. A pharmacist who combines clinical knowledge with comfort in data systems and technology is exceptionally well-positioned in this space.
  • Poison Control: Poison control centers are staffed largely by pharmacists, and it is a field that is highly dependent on drug and toxicology expertise. Poison Information Specialists answer calls from the public and healthcare providers about toxic exposures to medications, household chemicals, plants, and environmental agents, providing evidence-based guidance in real time. Many poison control positions offer competitive salaries, defined schedules, and the intellectual challenge of toxicology-focused clinical decision-making. For pharmacists who love the urgency and variability of clinical problem-solving without a traditional hospital setting, poison control is worth exploring.
  • Academia and Pharmacy Education: Pharmacists who are passionate about teaching, research, and mentorship may be drawn toward pharmacy academia. Faculty positions exist across the full spectrum of pharmacy programs from large research universities to smaller teaching-focused institutions. Many faculty positions blend responsibilities in teaching, scholarly activity, and clinical practice. These various tasks allow pharmacists to maintain a patient care component while contributing to the education of the next generation. Academic pharmacists also pursue research in areas ranging from pharmacoepidemiology and health outcomes to clinical pharmacology and pharmacy education science. A notable adjacent path is pharmacy education companies and content development organizations This includes test prep, continuing education, and professional development platforms. Pharmacists who enjoy writing, curriculum design, and communicating clinical knowledge at scale are building careers in this growing space. A great example is the many students and faculty who have contributed their expertise to platforms like RxPharmacist (the platform you’re on right now!).
  • Consulting: Pharmacist consultants work independently or within healthcare consulting firms to advise long-term care facilities, health systems, insurance companies, and government agencies on medication management strategies, regulatory compliance, formulary design, and clinical program development. Long-term care consultant pharmacy is a well-established niche, requiring pharmacists to conduct monthly medication regimen reviews for nursing home residents and make recommendations to prescribers. Independent pharmacy consultants also advise legal teams as expert witnesses in malpractice cases, work with startups navigating drug-related regulatory questions, and support healthcare organizations implementing quality improvement initiatives.
  • Military and Public Health Service: The U.S. military and the U.S. Public Health Service (USPHS) both commission pharmacists as officers, offering career paths that combine pharmacy practice with public service. Military pharmacists practice in a wide range of settings from stateside military treatment facilities to deployments supporting service members overseas. USPHS pharmacists serve in federal agencies including the FDA, Indian Health Service (IHS), Bureau of Prisons, and the CDC. These paths offer loan repayment benefits, structured career advancement, and the opportunity to serve populations that often have limited access to care. For students motivated by service and drawn to federal practice settings, military and USPHS pharmacy is a path worth considering.

Post-Graduate Training: Investing in Your Future

Regardless of the career path you are considering, post-graduate training can open doors, accelerate your timeline, and deepen your clinical or scientific foundation in ways that direct entry into the workforce may not. With that said, post-graduate training is not a requirement for every path in pharmacy, so the decision whether to pursue one of these options should be influenced by your ultimate career goals.

  • PGY-1 Pharmacy Residency: A PGY-1 (Post-Graduate Year 1) residency is a one-year, ASHP-accredited training program that provides intensive, supervised clinical experience across a variety of patient care settings. PGY-1 programs exist in hospitals, community pharmacy, managed care, and ambulatory care settings. Completing a PGY-1 develops advanced clinical skills, establishes professional networks, and is widely considered the minimum training requirement for competitive clinical pharmacy positions and most PGY-2 programs. The residency match process (conducted annually through the National Matching Services system) is competitive, and students who perform well on APPE rotations, build strong letters of recommendation, and articulate a clear professional vision tend to stand-out when Residency Program Directors are reviewing the large amounts of applicants.
  • PGY-2 Pharmacy Residency: A PGY-2 residency is a one-year specialty training program completed after the PGY-1. Specialty areas include critical care, infectious disease, oncology, cardiology, ambulatory care, psychiatry, pediatrics, solid organ transplant, emergency medicine, and many others. PGY-2 training is designed to prepare pharmacists for advanced specialist positions, leadership roles in clinical practice, or faculty positions with a clinical practice component.
  • Pharmacy Fellowship: Fellowships are research-intensive training programs that prepare pharmacists for careers in drug development, clinical research, medical affairs, regulatory science, or health outcomes research. These programs are most often conducted in the pharmaceutical industry or academia. Unlike residencies, fellowships are not standardized through ASHP accreditation. Therefore, program structure and duration vary, typically ranging from one to two years. Fellowships are the most direct post-graduate pathway into the pharmaceutical industry for new graduates. They generally attract students who are motivated by research, drug development, and population-level impact rather than direct patient care.
  • Graduate Degrees (MS, MBA, and PhD): Some pharmacists pursue graduate education alongside or after their PharmD to build expertise in a specific domain. An MS in Health Outcomes or Pharmacoepidemiology supports careers in outcomes research and managed care. An MBA opens doors into pharmaceutical industry leadership and healthcare administration. A PhD in Pharmaceutical Sciences, Clinical Pharmacy, or a related field is an option for pharmacists pursuing independent research careers and faculty positions at research-intensive institutions. Dual degree programs (PharmD/MBA, PharmD/PhD) are available at several schools and allow students to build these credentials in parallel with their pharmacy education.

Key Takeaway

Whether your path leads to a community pharmacy, a pharmaceutical company, a federal agency, a clinical informatics team, or a classroom, the clinical foundation built in pharmacy school is the common thread. The setting may change, but understanding drugs, patients, and evidence remains constant. Know that foundation well, and you will find a place to use it that genuinely fits who you are. Remember that even if you choose one path at the beginning of your journey, there is an entire world of possibilities. You may find your match on the first try, or you may need to endure some trial and error. Regardless, the key to success in your career is discovering what utilizes your strengths while also giving you a great sense of joy.

-APPE Student, Mollie Walters

References

  1. American Society of Health-System Pharmacists. Residency Program Directory and Accreditation Standards. Accessed June 29, 2026. https://www.ashp.org/professional-development/residency-information
  2. American College of Clinical Pharmacy. Residencies and Fellowships. Accessed June 29, 2026. https://www.accp.com/stunet/resfel.aspx
  3. U.S. Food and Drug Administration. FDA Pharmacy Student Experiential Program. Accessed June 29, 2026. https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/fda-pharmacy-student-experiential-program
  4. U.S. Public Health Service Commissioned Corps. Pharmacist. U.S. Department of Health and Human Services. Accessed June 29, 2026. https://www.usphs.gov/professions/pharmacist/
  5. American Society of Consultant Pharmacists. What Is a Consultant Pharmacist? Accessed June 29, 2026. https://www.ascp.com/page/whatisacp
  6. U.S. Bureau of Labor Statistics. Occupational Outlook Handbook: Pharmacists. U.S. Department of Labor. Accessed June 29, 2026. https://www.bls.gov/ooh/healthcare/pharmacists.htm
  7. Centers for Disease Control and Prevention. Translational Tools for Pharmacists. Published April 2024. Accessed June 29, 2026. https://www.cdc.gov/high-blood-pressure/media/pdfs/2024/04/Translational_Tools_Pharmacists.pdf
  8. Florida Poison Control Centers. Employment. Accessed June 29, 2026. https://floridapoisoncontrol.org/contact/employment/

Pharmacy Career Paths You Didn’t Learn About in School Read More »

Rotation Testimonial: How RxPharmacist Prepares for Residency, Fellowship, and Entry-Level Pharmacy Roles

Throughout this rotation I gained a wide variety of skill sets that will be valuable for my future as a PGY-1 resident and as a future pharmacist. One of the most significant areas that I grew in was my written communication. Throughout this rotation I had to translate clinical and regulatory information for different audiences. I grew in my ability to deliver clear, concise, engaging, and grammatically correct written information. This will help me in my residency as I will have to create projects and presentation involving written communication.

During my rotation with RxPharmacist, I also learned how to effectively deliver verbal communication through delivering lecture presentations. I became more comfortable organizing and delivering information in a structured, engaging manner while also maintaining professionalism. Recording presentations required attention to pacing, articulation, and audience engagement – all of which I improved on throughout the course of my rotation based on valuable feedback from my preceptor.

Additionally, this rotation required me to find primary sources to complete projects. I strengthened my ability to differentiate between the sources I was using for my projects in order to find the most reliable information to deliver. This is an essential skill in my future as a pharmacist as it supports evidence-based decision making and ensures that recommendations and educational materials are based off the most current and credible data.

Finally, this rotation assisted my growth in adaptability and self-directed learning. Many of the tasks required me to independently research unfamiliar topics, apply new tools, and continuously revise my work based on feedback. Using a growth mindset increased my confidence in navigating new challenges, which is essential in the ever-evolving field of pharmacy.

Overall, the skills I developed during this rotation – communication, educational design, critical thinking, organization, time management, and adaptability have strengthened my ability to contribute to both patient care and professional education in pharmacy.

I am extremely grateful to have had the opportunity to be on this rotation. I appreciate the guidance that I received from my preceptor and the valuable feedback that he provided me to strengthen my medical writing skills. I appreciated having the pre-rotation meeting, as it made me feel like I had a say in the projects that I wanted to work on. This was a great way to end my APPE year. Thank you RxPharmacist!

-Olivia J., University of Minnesota

Rotation Testimonial: How RxPharmacist Prepares for Residency, Fellowship, and Entry-Level Pharmacy Roles Read More »

RxPharmacist Rotation Student Reflection: Learnings, Impact, and Experience

During my rotation with RxPharmacist, I entered the experience feeling intrigued but uncertain about what to expect. Unlike clinical rotations that emphasize direct patient care, this setting centered around education, content development, and creativity. For clinical rotation I had a general idea of what my days would look like. For this rotation, I did not have a clear picture of what my daily responsibilities would be going into it.  However, this initial unpredictability became one of the most valuable aspects of the experience, as it encouraged me to approach each task with an open mind and a willingness to step outside of my comfort zone. Over time, I came to appreciate how integral education and effective communication are to the pharmacy profession, even outside of direct patient interactions.

Throughout the rotation, I had the unique opportunity to actively participate in selecting the types of assignments I wanted to complete. This allowed me to not only build on my existing strengths but also intentionally challenge areas where I felt less confident. One of my responsibilities was creating multiple continuing education (CE) courses for different states. This experience significantly expanded my understanding of pharmacy law beyond my state and exposed me to different regulations across various state jurisdictions. This work required me to navigate legislative documents and regulatory language, unlike the clinical research I was more accustomed to in previous years of pharmacy school. However, through repeated practice I developed stronger research skills, particularly in identifying credible sources and interpreting complex information. This process broadened my perspective on the different types of research pharmacists may encounter and reinforced the importance of being adaptable in how information is gathered and analyzed.

In addition to strengthening my research abilities, developing CE courses also improved my writing skills. I learned how to present information in a way that is clear, concise, and engaging. Writing is often a skill that remains in the background during pharmacy school, where the focus is typically on memorization and clinical application. However, this experience highlighted how essential strong writing skills are, especially when creating educational materials or communicating important information. Being able to translate complex concepts into digestible content is a skill that applies directly into patient counseling and professional communication. As I progressed through the rotation, I became more confident in my ability to write efficiently and purposefully, which I anticipate will benefit me in both academic and professional settings. On top of that, I gained a new appreciation for the professionals who provide educational material and their hard work.

Another major component of my rotation involved updating the Pennsylvania MPJE guide and the Retail OTC guide. At first, this task felt overwhelming due to the length and complexity of the documents. I found myself needing to re-familiarize with formatting tools and carefully review large amounts of existing content. However, this challenge quickly became an opportunity for growth. Rather than passively reading, I had to critically evaluate the material and consider what could be improved, clarified, or expanded. This process strengthened my attention to detail and encouraged me to adopt a more proactive mindset by asking myself, “What can I contribute?” Over time, I became more comfortable suggesting changes and thinking creatively about how to enhance the guides. This shift in perspective improved the confidence in my ability to contribute meaningful ideas, which was an area I had previously struggled with.

In addition to written content, I also created five presentations and corresponding video lectures. This aspect of the rotation allowed me to further develop my communication and educator skills while also exploring my creativity. Designing presentations required me to carefully consider how to organize information in a way that is visually appealing and easy to understand. Initially, I found this challenging, as creativity and graphic design was not something I considered a strength. However, with practice I began to experiment with different layouts, visuals, and methods of presenting information. I noticed a clear improvement in the quality of my work over time. Recording video lectures was a completely new experience for me, as it involved learning how to use an unfamiliar platform for recording and editing. Although recording myself initially felt intimidating and a little awkward, it ultimately became one of the most enjoyable parts of the rotation. Hearing my own recordings also allowed me to reflect on my pacing, tone, and diction, helping me improve on public speaking skills that will be valuable in both professional presentations and patient interactions.

Across all of these assignments, one of the most consistently challenging yet rewarding tasks was creating practice questions. At first, I underestimated how difficult it would be to design effective questions. I quickly realized that in order to create meaningful questions, I needed to have a strong understanding of the material and be able to anticipate how learners might interpret and apply the information. Striking a balance between questions that were too simple and those that were appropriately challenging required significant thought and effort. However, this process ultimately strengthened my critical thinking and problem-solving skills. By the end of the rotation, I felt more confident in my ability to create questions that not only assess knowledge but also encourage deeper understanding and application.

This rotation also reinforced the importance of adaptability. Many of the tasks required me to learn how to use new platforms, websites, and tools. It also required me to have a more comprehensive understanding of tools I had used before. However, being able to quickly adapt to new systems and technologies is an essential skill in modern pharmacy practice. Whether learning a new electronic health record system or adapting to updated clinical guidelines, pharmacists must be able to navigate change effectively. This experience helped me become more comfortable with learning new tools and approaching unfamiliar tasks with a problem-solving mindset rather than hesitation.

Overall, the skills I developed during this rotation will directly support my future career goals in hospital or ambulatory care pharmacy. The research and writing skills I exercised will be valuable when composing patient notes, consults, and other forms of clinical documentation. My experience with presentations and video lectures will enhance my ability to communicate effectively with both colleagues and patients. Additionally, the attention to detail I developed while updating the guides will be critical in ensuring accuracy and safety in medication management. Finally, the creativity and problem-solving skills I cultivated will allow me to approach complex clinical situations with greater flexibility and confidence.

In conclusion, my experience with RxPharmacist was both unexpected and highly impactful. While it differed significantly from traditional clinical rotations, it provided me with opportunities to develop a wide range of transferable skills. Each assignment challenged me in new ways and contributed to my growth in communication, writing, creativity, and critical thinking. By the end of the rotation, I not only gained a deeper appreciation for the role of education in pharmacy but also developed greater confidence in my ability to adapt and contribute meaningfully in unfamiliar settings. This experience has reinforced the importance of continuous learning and effective communication, both of which will be essential as I continue to grow in my career as a pharmacist.

-Hannah Y., University of Pittsburgh

RxPharmacist Rotation Student Reflection: Learnings, Impact, and Experience Read More »

Mastering the UMPJE & MPJE: A Guide to Law Exam Success

Overview

In 2025, the average first-time pass rate for the Multistate Pharmacy Jurisprudence Examination (MPJE) was 73.6%. This is lower than the pass rate of 2024 (74.8%), but higher than the average in 2023 (71.5%). As of 2026, the UMPJE has been released. This new exam has slowly been transitioned in, and only some states have adopted it thus far. Many pharmacy students find the law exam to be intimidating. For example, the questions are often phrased in a way where there could potentially be multiple right answer choices, but you have to carefully think about what the best answer is. In this blog, we will break down the MPJE/UMPJE and several strategies for students and pharmacists preparing for the exam.

First-time Pass Rates for the MPJE
Chart: canva.com

MPJE or UMPJE: What is the Difference?

The MPJE was adopted in 1998 and is an exam that is taken by a pharmacist seeking licensure.  This test is delivered based on jurisdiction and includes statutes and regulations of one specific state that a candidate is seeking licensure in. Additionally, the MPJE also covers federal law. In 2026, the National Board of Pharmacy (NABP) released the UMPJE, which covers a more universal law approach in which the content is applicable to all jurisdictions. The states that have switched from the MPJE to the UMPJE starting April 1st, 2026, include Arizona, Florida (effective June 1st, 2026), Iowa, Kansas, Maryland (effective June 1st, 2026), North Carolina, Ohio, and Rhode Island. More states can be expected to follow suit in the future. At the end of this blog, you can find an interactive map that lists states that will be adopting this new exam. The UMPJE was designed to allow pharmacists to practice in multiple states while reducing the burden of preparing for multiple tests, reducing costs, and allowing a faster time to licensure. The features of the exams are quite similar with some small variations which are described in the chart below.

Chart: canva.com

Breaking Down the Content Areas:

The UMPJE and MPJE have slightly different focus areas. NABP breaks down each exam into these 4 different areas that encompass the exam. In addition, the organization also relays what percentage of the content will come from each domain. Below is a brief breakdown of the different content areas between the exams.

MPJE:

  • Licensure/Personnel – makes up 22% of the total exam
    • Covers pharmacist responsibilities and other duties related to pharmacists as well as non-pharmacist workers
  • Pharmacist Practice – makes up 33% of the total exam
    • Covers information on issuing medications, drug administration, counseling, pharmacy related agencies, and reusing medications
  • Dispensing Requirements – makes up 24% of the total exam
    • Covers the evaluation of prescription orders, transfer of prescriptions, drug utilization reviews, dispensing exceptions, labeling/packing of medications, distribution/dispensing of products
  • Pharmacy Operations – makes up 21% of the total exam
    • Covers ordering medications, recordkeeping, drug delivery, product selection, compounding, central-fill pharmacies, requirements of a pharmacy related setting
Graph: canva.com

UMPJE:

  • Pharmacy and Pharmacist Practice – makes up 30% of the exam
    • Covers scope of pharmacy, non-pharmacist workers, adulteration/misbranding drugs, federal standards, compounding, patient protected health information
  • Medication Use Process – makes up 30% of the exam
    • Covers requirements of issuing orders, dispensing, and the administration of medications
  • Regulatory Authority and Legal Obligations – makes up 20% of the exam
    • Covers regulatory authorities, controlled medications, and liability
  • Pharmacy operations – makes up 20% of the exam
    • Covers licenses, technology, and the storage/security and handling of medications
Graph: canva.com

Understanding Question Architecture

The MPJE/UMPJE questions are formatted in 3 different ways: multiple choice, select all that apply, and K-type multiple choice. Multiple choice questions give 4 to 5 possible answer choices, and you have to choose the one that is most correct. These can be challenging in that multiple responses may seem correct, but you have to pick the best response. The next type of question format is select all that apply. This structure can also be difficult for test takers as there is no partial credit. Even if you miss 1 response, the entire question will be marked wrong. Lastly, the exam will consist of K-type questions. The question will include statements which are labeled with roman numerals, and you answer the question by choosing a combination of the statements, or by strictly choosing just one of the statements. A word of advice while answering these types of questions – treat the roman numeral labeled statements as if they were true/false statements. If you rule out one of the statements, then you may be able to disregard multiple potential answers given for the question.

On another note, it is important to go slow and read the entirety of the question. The exam frequently includes statements such as “which does not apply” or “all of the following apply, except.” It is also important to understand the difference between “must,” “shall,” and “may” as these words also frequent on the exam. Be sure to check out our online courses to get practice with all these types of questions!

Study Strategies for Success

When starting to study for this exam, try to focus on active learning rather than just reading through the laws and regulations. Strictly reading the material may not work as well as active learning – writing things down, underlining, flash cards. Apply what you have read to real-life examples. Below are some big topics that frequently appear on the exam and are often the most difficult for students:

  • Controlled Substances – any topic surrounding controlled substance is frequently asked
  • Dispensing medications – prescription requirements, labeling requirements, and counseling are big topics
  • Record keeping – identifying how long you need to keep records, storage of medications, etc.
  • Non-pharmacist personnel – the role of technicians/interns in the pharmacy as well as the ratio of technicians to pharmacists
  • Licensure – this could include continuing education hours, how to renew licenses, malpractice, and more
  • Compounding – topics related to sterile, non-sterile, and hazardous compounding
  • Pharmacist In Charge (PIC) – responsibilities and duties related to operation

When studying for the UMPJE, it is important to keep in mind that the questions are based on a universal approach – topics that are applicable to multiple jurisdictions. If you are taking this exam, it is still important to know your specific state requirements as well. Alternatively, the MPJE is focusing on federal and state law. Occasionally, the state will differ from the federal law. Keep in mind that you should follow the stricter law and answer the question based on that. Listed below are some study tips for you to consider during the study process:

  • Formulate a study plan – create a study plan to follow. You could include what topics to focus on each day, when you will do practice questions, and save the practice exam for when you are getting close to the exam. It is okay to change your plan when you find out what you need more practice with.
  • Designate a set amount of time – give yourself enough time to prepare! Many students find that studying for 3-6 weeks is a good duration to study. Base this off of what works for you!
  • Enroll in an online course – find an online course that includes lectures, study guides, practice quizzes, and practice exams. Check out our state-specific MPJE courses here and our new UMPJE course here!
  • Create a self-care routine – when studying, it is important to still give yourself time to decompress and do things for yourself. This will help prevent study burnout!
Image: unsplash.com

Your Plan for Test Day

Many different emotions can occur on your test day for the MPJE/UMPJE. Some may find themselves anxious and/or stressed prior to taking the exam, but may have relief when getting this intimidating exam out of the way. To get through this day, here are some test day tips that you can follow:

  • Prepare what you bring – NABP requires you to bring a valid form of ID (such as a driver’s license, passport, etc.) Ensure that your ID is not expired!
  • Plan to arrive early – Show up at least 30 minutes before your testing time to allow enough time to go through the check-in process. Being late will only add to stress/anxiety on the day of the exam.
  • Perform with focus during the exam
    • Read each question thoroughly and carefully
    • Answer the question with a pharmacist mindset – not a “test-taking” mindset
    • Use the process of elimination as stated previously! Treat each statement as if it were a true/false question
    • Follow your gut – think about what both the right and cautious thing is to do
    • Pace yourself as you have about 1 minute and 25 seconds per question
  • Proceed with confidence after the test – Pat yourself on the back for being done with the exam! Try not to stress about the results during the waiting period.

Study Smart and Pass Confidently

Approaching the MPJE/UMPJE with an intentional and strategy-driven study mindset can help make this process manageable. Stay up to date with what your state requires in regard to the law exam to help guide your studying – is it the federal & state law (MPJE) or is it the uniform and universal approach to law (UMPJE)? To set yourself up for success, create a personalized plan with deadlines, costs, study materials, and test-day concepts. Guide your focus on real-world applications rather than strictly memorizing the law. Remember, this exam is testing your knowledge to practice safe and competent duties as a pharmacist. Be consistent, trust yourself, and approach test day knowing you have built the skills needed to navigate the pharmacy law.

Olivia Johnson, PharmD

RxPharmacist Uniform MPJE Adoption Tracker

References:

  1. Multistate Pharmacy Jurisprudence examination passing … Accessed April 3, 2026. https://nabp.pharmacy/wp-content/uploads/MPJE-Pass-Rates.pdf.
  2. Pharmacy Law Examination Preparation Guide. Accessed April 3, 2026. https://www.ashp.org/-/media/assets/new-practitioner/docs/2025/Pharmacy-Law-Examination-Preparation-Guide_ASHP-NPF.pdf
  3. Competency Statements | Multistate Pharmacy Jurisprudence Examination. National Association of Boards of Pharmacy. https://nabp.pharmacy/programs/examinations/mpje/competency-statements/
  4. Multistate Pharmacy Jurisprudence Examination (MPJE) | NABP. National Association of Boards of Pharmacy. https://nabp.pharmacy/programs/examinations/mpje/
  5. Understanding the Uniform MPJE for Pharmacy Licensure | MPJE. National Association of Boards of Pharmacy. Published May 15, 2025. https://nabp.pharmacy/programs/examinations/mpje/uniform-mpje/
  6. Uniform Multistate Pharmacy Jurisprudence Content Outline. Accessed April 3, 2026. https://nabp.pharmacy/wp-content/uploads/Uniform-MPJE-Content-Outline.pdf.
  7. Section 1 | Welcome. Nxtbook.com. Published 2026. Accessed April 3, 2026. https://read.nxtbook.com/nabp/bulletin/naplex_mpje_bulletin/welcome.html

Mastering the UMPJE & MPJE: A Guide to Law Exam Success Read More »

Optimizing Pharmacotherapy in Older Adults: Rethinking Anticholinergics in Geriatric Care

Overview

In 2020, in terms of our aging population in the United States, there were approximately 47 million adults ages 65-84 and 7 million adults ages 85 and older. In 2040, the number of adults that are 85 and older is expected to double with about 15 million people falling into this category and ages 65-84 continuing to increase to approximately 65 million adults.

Graph: canva.com

With this aging population, we can expect to see an increase in health conditions such as dementia, chronic obstructive pulmonary disease (COPD), urinary incontinence, depression, sleep disorders, and more. To treat these conditions, medications are commonly prescribed with the thought to improve the functions of daily living. Unfortunately, many of the medications that are prescribed have anticholinergic properties and may result in adverse effects in the elderly population. These side effects could potentially contribute to a patient’s physical and mental decline. Pharmacists play an important role in recognizing high-risk medications and recommending alternative pharmacological and non-pharmacological agents that could be safer in the elderly patient population.

Understanding Anticholinergic Medications

Acetylcholine is a neurotransmitter that allows communication between neurons in the body and contributes to muscle movement, memory, learning, glandular secretion, and more.  Anticholinergic medications work by blocking acetylcholine from binding primarily to the muscarinic receptors and to a small degree, nicotinic receptors. Medications with anticholinergic effects result in relaxation of smooth muscles as well as reducing the production of bodily secretions. Below are some frequently prescribed anticholinergic medications.

Table: canva.com

While not explicitly stated in the Beers Criteria, we also frequently see medications that are used for overactive bladder and urinary incontinence being prescribed in older adults. These include medications such as oxybutynin, tolterodine, and solifenacin, just to name a few. As previously explained, these medications relax the smooth muscle of the bladder to cause urinary retention.

The Beers Criteria Explained

The Beers Criteria is a list created by the American Geriatrics Society (AGS) on potentially inappropriate medications in adults who are 65 and older. The aim is to help guide practitioners in choosing safe medications for older adults. It is important to keep in mind that this is just a general list – it is not patient specific. Practitioners must use their clinical judgement when recommending and prescribing medications on the Beers Criteria in a patient-centered approach. This list is updated every 3 years, with the most recent update being in 2023. As of today, the AGS has not yet released the 2026 version.

Recognizing the Anticholinergic Risk

Anticholinergic medications affect the central nervous system (CNS). These central effects can lead to confusion, delirium, cognitive dysfunction, memory issues, dizziness, and sedation. This is of big concern with our older population because it puts the patients at risk of falls and potential memory problems. In addition to affecting the CNS, anticholinergic medications also impact the peripheral nervous system. The peripheral effects can lead to “drying” effects as we commonly describe to patients. This includes urinary retention, constipation, blurry vision, and dry mouth. These effects are often bothersome to most patients.

Some patients may be on multiple high-risk medications. This can lead to something called an “anticholinergic burden”. If patients are on these kinds of medications long-term, it could also lead to an “anticholinergic burden”. A tool has been created to assess a patient’s risk of this effect, and it is called the “ACB Scale”. If a patient scores 3 or higher, then this puts them at higher risk of mortality and cognitive impairment.

Image: unsplash.com

What Makes Older Adults So Vulnerable?

As people age, the body starts to make less acetylcholine, and due to the mechanism of action described above, this results in a higher proportion of acetylcholine being blocked with anticholinergic medications. This leads to more potent effects in the elderly population. Additionally, a reduction in metabolism and excretion through the liver and kidney occurs as people age which can cause accumulation of anticholinergic medications and increasing effects. Lastly, the blood brain barrier becomes more permeable with age, resulting in the CNS effects described previously.

Potential Dementia Risks

While a direct link between anticholinergic medications and dementia has not been found, several studies have noted an association between patients who take anticholinergic medications and developing dementia. One study in Harvard Health Publishing found that a patient taking an anticholinergic medication long-term was associated with a 54% higher risk of developing dementia. It is important to note that the increased risk is associated with longer durations and higher doses, leading to an increased exposure – often referred to as the anticholinergic burden. However, other studies have not found a link between these kinds of medications and dementia. These other studies identified that the underlying conditions may actually put one at risk of developing dementia, not the medications themselves. Evidence suggests that the cognitive dysfunction that may occur with anticholinergic medication may be reversible after discontinuation of the offending agent, although this can’t be guaranteed, especially with an increased exposure. More data is needed to draw a conclusion about the long-term dementia risk that has been casually associated with anticholinergic medications.

Alternatives to Anticholinergics

At this point, one may be asking, “if not an anticholinergic, then what?” Well, there are other options that have been shown to be safer and still effective in older adults. Below is a chart similar to the one above that describes alternative pharmacologic options. These medications have been identified to have a lower anticholinergic risk than others in the same class.

Chart: canva.com

Anticholinergic medications may still be deemed necessary in some patients. It is important to use clinical judgement and treat each patient individually in a patient-centered approach. As long as the benefits outweigh the risks, then these medications may still be used.

Additionally, non-pharmacological strategies may also play a role in reducing the reliance on anticholinergic medications. For example, patients with allergies may benefit from approaches such as allergen avoidance – keeping windows closed during pollen seasons or washing bedding regularly. In the management of depression, cognitive behavioral therapy (CBT) has demonstrated to be effective. For musculoskeletal discomfort, alternatives such as massage therapy or heat (e.g., heating pad) may reduce the need for muscle relaxants. Lastly, older adults experiencing overactive bladder or incontinence may find pelvic floor training a helpful tool to avoid anticholinergic medications and improve bladder control.

Pharmacist Considerations

Pharmacists play a vital role in identifying patients at risk for adverse effects associated with anticholinergic medications. Through careful medication review, pharmacists are well positioned to recognize individuals who may be susceptible to these effects. Deprescribing, as clinically indicated, is another key responsibility that pharmacists can engage in to reduce anticholinergic burden. In addition to educating patients, pharmacists can also guide providers by recommending safer, evidence-based alternatives. Services such as medication therapy management (MTM) further support this effort, especially for pharmacists who practice under collaborative practice agreements (CPAs) and have the ability to prescribe/deprescribe medications. By using this interprofessional collaboration, pharmacists can make meaningful impacts on patients’ health, ultimately improving safety, outcomes, and quality of life.

The Big Picture

As the U.S. population continues to age, the risks associated with anticholinergic medications become increasingly important to recognize and address. These agents are frequently used and are often effective, but their potential to contribute to cognitive dysfunction, falls, and decreased quality of life – specifically in older adults – is something to be talked about. Clinicians can make more informed prescribing decisions after understanding how these medications work and applying tools such as the Beers Criteria and ACB scale to help guide their decisions. Pharmacists are in a position to identify anticholinergic burden, recommend appropriate changes, and use interprofessional collaboration, along with patient input, to optimize therapy. Ultimately, careful medication management can minimize one’s anticholinergic exposure. Small changes may make big impacts on cognition and quality of life.

Olivia Johnson, PharmD

References:

  1. From The American Geriatrics Society. https://thecarepartnerproject.org/wp-content/uploads/The-Beers-List.pdf
  2. Ghossein N, Kang M, Lakhkar AD. Anticholinergic medications. PubMed. Published 2023. https://www.ncbi.nlm.nih.gov/books/NBK555893/
  3. Urban Institute. The US population Is aging. Urban Institute. Published December 12, 2019. https://www.urban.org/policy-centers/cross-center-initiatives/program-retirement-policy/projects/data-warehouse/what-future-holds/us-population-aging
  4. Mayo Clinic. Bladder control: Medications can relieve urinary problems. Mayo Clinic. Published 2017. https://www.mayoclinic.org/diseases-conditions/urinary-incontinence/in-depth/bladder-control-problems/art-20044220
  5. King R, Rabino S. ACB Calculator. www.acbcalc.com. Published December 17, 2023. https://www.acbcalc.com/
  6. Ruscin JM, Linnebur SA. Aging and Medications. Merck Manual Consumer Version. Published April 6, 2025. https://www.merckmanuals.com/home/older-people-s-health-issues/aging-and-medications/aging-and-medications#Benefits-and-Risks-of-Prescription-Medications_v838778
  7. Harvard. Common anticholinergic drugs like Benadryl linked to increased dementia risk – Harvard Health. Harvard Health. Published January 28, 2015. https://www.health.harvard.edu/blog/common-anticholinergic-drugs-like-benadryl-linked-increased-dementia-risk-20150128812
  8. Hanlon JT, Semla TP, Schmader KE. Alternative Medications for Medications in the Use of High-Risk Medications in the Elderly and Potentially Harmful Drug-Disease Interactions in the Elderly Quality Measures. Journal of the American Geriatrics Society. 2015;63(12):e8-e18. doi:https://doi.org/10.1111/jgs.13807
  9. Deglow B. Pharmacist-Driven Deprescribing to Reduce Anticholinergic Burden in Veterans With Dementia. Federal Practitioner. 2024;41(12). doi:https://doi.org/10.12788/fp.0539

Optimizing Pharmacotherapy in Older Adults: Rethinking Anticholinergics in Geriatric Care Read More »

Fewer Injections, Same Control? A New Outlook on Basal Insulin Medication for Patients with Type 2 Diabetes

Overview

Patients with type 2 diabetes mellitus (T2DM) requiring insulin therapy currently have multiple options to choose from between bolus (short-acting) insulin, basal (long-acting) insulin, and premixed (long-acting and rapid/intermediate). Studies have reported the number of patients with T2DM using insulin have continued to increase with approximately 109,974 users in 2002 and reaching 348,254 users in 2019. No matter which type of insulin a patient is on, daily injections are still required.

 Graph: canva.com

When initiating insulin therapy in T2DM patients, the American Diabetes Association recommends starting patients on basal insulin alone before transitioning to a basal/bolus regimen. In order for insulin injections to be effective, patients must be adherent to their dosing schedule. A post-hoc analysis published in the Diabetes Research and Clinical Practice reported that the weekly averages of T2DM patients being adherent to their basal insulin regimen ranged from 70.6% to 79.3%. A recently approved once-weekly injection could not only promote adherence, but it could also reduce the burden of daily injections associated with basal insulin as well as providing patients with the potential for stable, long-lasting glucose control.

The Arrival of a New Era in Insulin Therapy

On March 26th, 2026, the US Food and Drug Administration (FDA) approved Awiqli® (insulin icodec-abae), a novel once-weekly basal insulin for the treatment of type 2 diabetes. Awiqli® is to be injected every 7 days, on the same day each week, offering a more convenient dosing schedule compared to current once daily basal insulins. Trials from the ONWARD program demonstrated non-inferiority and, in some cases, superiority when compared to the standard insulin degludec and glargine. The primary outcome measured included a reduction in hemoglobin A1c. The insulin icodec group had a reduction of 8.6% to 7.0% meanwhile the insulin degludec group had a reduction of 8.5% to 7.2%.

Graph: canva.com

The Science Behind Once-Weekly Control

Awiqli® mimics the natural insulin that the body produces and binds to human insulin receptors. The insulin is highly protein bound (>99%) resulting in a half-life of approximately 7 days which allows for the once-weekly dosing. Once bound, a depot is formed in the bloodstream which allows the insulin to be slowly released over time and results in gradual and consistent glucose control. Steady state is reached after a couple of weeks of injections and will further maintain a continuous, steady equilibrium.

Although this insulin has many promising factors, there are some instances where a clinician may want to proceed with caution in recommending this product for a patient. Due to the long half-life, this medication remains in the body for a longer period of time. If the medication is dosed too high, the patient could experience more frequent hypoglycemic episodes. The same can be said if a patient experiences an allergic reaction. It will take longer for the body to excrete this medication compared to the current basal insulin therapies.

The Art of Dosing Once-Weekly Insulin

Awiqli® is formulated into a pre-filled pen that contains 700 units/mL. The pen is designed to deliver doses rounded to the nearest 10-unit increment (e.g. 70 units, 80 units, 90 units, and so on).

The manufacturer, Novo-Nordisk, recommends starting patients on 70 units once weekly if the patient is basal insulin naïve, then titrating as necessary. Alternatively, if the patient is switching from a daily basal insulin to Awiqli®, the first week dose is calculated by multiplying the patient’s current daily basal dose by 1.5 then further multiplying this by 7 and rounding to the closest 10 units. For the second week, take the patient’s previous total daily dose of basal insulin, multiply this by 7, and round to the closest 10 units. After the second week, it is recommended to continue titrating as clinically indicated.

Table 1: How to dose Awiqli® based on manufacturer guidelines
Table: canva.com

Practice Pearls for Pharmacists

Although a once-weekly injection sounds like the ideal insulin regimen, it may not be the best choice for all patients. With the recent FDA approval, it was only approved for patients with T2DM. Patients with type 1 diabetes mellitus (T1DM) were included in studies, but it was not approved in this patient population due to an increased risk of hypoglycemia. Furthermore, it was only studied in adults aged 18 and older, so therefore, it is not approved in children.

A patient that could be a good candidate for this novel basal insulin therapy may be one who struggles with adherence, varying glucose control, or someone just overwhelmed with daily injections. With the once-weekly dosing, pharmacists play a key role in educating patients on Awiqli®. Some important considerations include:

  • Emphasizing a once-a-week injection rather than daily – the dose is much higher than standard daily dosing so an administration error of injecting the prescribed dose daily could result in extreme episodes of hypoglycemia.
  • Educating on how to combat hypoglycemia – since this medication sticks around longer in the body, if the dose is too high (especially if the patient is taking other anti-glycemic medications), then hypoglycemic episodes could potentially last longer and/or occur more frequently.
  • Monitoring daily blood glucose levels – when the patient is starting out on Awiqli®, the dose may need to be titrated, so having current and accurate blood glucose readings will help guide these dose changes.
  • Missing doses – if a patient misses a dose, it is best to take the dose as soon as possible if it is within 4 days of the injection date. If it has been more than 4 days, it is best to wait until the next scheduled injection date.
Image: unsplash.com

The Patient Experience with Once-Weekly Insulin

As stated previously, patient adherence to prescribed anti-glycemic therapy is important in maintaining blood glucose control and preventing hyperglycemic episodes that could lead to a wide array of health complications. The novel once-weekly mechanism provides an option for patients who are struggling with adherence resulting in varying glucose control. It also has a role for patients who are just overwhelmed with the burden associated with managing their T2DM and daily basal insulin injections.

Patients can expect to see this medication being available in the coming months of 2026. The cost of Awiqli® is still not readily available. Due to this being a new medication and with recent FDA approval, it could be expected to be on the more expensive end. It will also be interesting to see what insurance coverage looks like in the coming months. Will insurances require a prior authorization? Will step therapy be required? Access to this medication will determine if patients will actually be able to benefit from it.

Is Weekly the Future of Diabetes Care?

While the number of patients with T2DM using insulin therapy continue to rise, we continue to see poor adherence leading to poor glucose control among this patient population. The newly FDA approved medication Awiqli® (insulin icodec-abae), could help target this specific patient population with providing the possibility of better adherence and decreased injection burden due to the medication’s once-weekly dosing. In addition, it could benefit patients who have varying glucose control with the mechanism of action of forming a depot in the bloodstream to provide a slow, constant, and steady release of insulin. This medication is not without its challenges. Dosing has to be just right because if it is too high, the patient could experience prolonged hypoglycemic episodes. Patient access to this medication in regard to cost and insurance coverage still remains a topic of discussion. What comes next is still up in the air. Practitioners could expect to see changes in diabetes guidelines in the future which could potentially impact the standards of care in patients with T2DM. This may be the end of a chapter for previous therapies, but this is a promising start of a new era in basal insulin therapy.

Olivia Johnson, PharmD

References:

  1. Highlights of prescribing information. Accessed March 31, 2026. https://www.novo-pi.com/awiqli.pdf
  2. Pharmacytimes.com. Published 2026. Accessed March 31, 2026. https://www.pharmacytimes.com/view/fda-approves-insulin-icodec-abae-first-once-weekly-basal-insulin-for-adults-with-t2d
  3. Home: Awiqli. Awiqli.ca. Published 2026. https://awiqli.ca/en/
  4. Ajmc.com. Published 2026. https://www.ajmc.com/view/fda-approves-novel-weekly-basal-insulin-for-t2d
  5. Awiqli | European Medicines Agency. www.ema.europa.eu. https://www.ema.europa.eu/en/medicines/human/EPAR/awiqli
  6. Weekly insulin found safe, effective for Type 2 diabetes. Utsouthwestern.edu. Published July 12, 2023. https://www.utsouthwestern.edu/newsroom/articles/year-2023/july-weekly-insulin-found-safe.html
  7. Park J, Kim G, Kim BS, et al. Insulin Fact Sheet in Type 1 and 2 Diabetes Mellitus and Trends of Antidiabetic Medication Use in Insulin Users with Type 2 Diabetes Mellitus: 2002 to 2019. Diabetes & Metabolism Journal. Published online February 7, 2023. doi:https://doi.org/10.4093/dmj.2022.0346
  8. American Diabetes Association. Insulin Basics | ADA. diabetes.org. Published 2024. https://diabetes.org/health-wellness/medication/insulin-basics
  9. Toft J, Kronborg T, Jensen MH, Rana P, Vestergaard P, Stine Hangaard. Assessment of basal insulin adherence in people with type 2 diabetes in telemonitoring: Post-hoc analysis of novel data modalities including insulin injection data. Diabetes Research and Clinical Practice. Published online April 1, 2025:112191-112191. doi:https://doi.org/10.1016/j.diabres.2025.112191
  10. Miller K. Awiqli, a Once-a-Week Insulin Shot for Type 2 Diabetes, Gets FDA Approval. EverydayHealth.com. Published 2026. Accessed March 31, 2026. https://www.everydayhealth.com/diabetes/once-a-week-insulin-shot-is-a-game-changer-for-type-2-diabetes/

Fewer Injections, Same Control? A New Outlook on Basal Insulin Medication for Patients with Type 2 Diabetes Read More »

Anaphylm (Dibutepinephrine): A New Frontier in Anaphylaxis Management

Introduction

Anaphylaxis is a serious, systemic hypersensitivity reaction characterized by rapid onset and the potential for life-threatening progression within minutes. In many cases, symptoms escalate in seconds, turning an ordinary moment at a restaurant, school event, or family gathering into a medical emergency. If left untreated, anaphylaxis may lead to loss of consciousness, cardiac arrest, or death. According to the Allergy and Asthma network, approximately 1 in 20 Americans have experienced anaphylaxis. Among individuals with food allergies, 42% of children and 51% of adults report a history of severe reactions. The economic burden is also substantial, with an estimated $1.2 billion in annual direct medical costs in the United States, including roughly $294 million attributed to epinephrine prescriptions alone. Anaphylaxis is associated with approximately 225 deaths per year in the U.S., and notably, about half of all episodes occur at home.

Epinephrine remains the only medication capable of reversing the life-threatening symptoms of anaphylaxis and is universally recognized as the cornerstone of management. In theory, that makes the solution sound straight forward—recognize symptoms and administer epinephrine immediately. In practice, it’s more complicated. Despite clear guideline recommendations, epinephrine continues to be underutilized. In a nationwide survey conducted by Wood and colleagues, 52% of patients who had previously experienced anaphylaxis had never received a prescription for an epinephrine auto-injector (EAI), and 60% did not have one currently available. Barriers include needle phobia, fear and anxiety surrounding device use, lack of confidence in administration technique, and misconceptions that a prescription is unnecessary. Delayed administration is associated with more severe outcomes, including biphasic reactions and increased risk of fatality. When it comes to anaphylaxis, hesitation can be costly—timely epinephrine use is strongly correlated with improved survival.

This gap between what should happen and what actually happens has fueled interest in alternative delivery systems. Anaphylm, an investigational sublingual epinephrine film developed by Aquestive Therapeutics, is being studied as a potential alternative to injectable epinephrine products.The film is small and lightweight, designed to dissolve under the tongue without the need for water or swallowing, and is packaged in a compact, weather-resistant format. While still under regulatory review, the concept raises important questions for pharmacists—Could a needle-free option improve willingness to carry epinephrine? Would simpler administration reduce delays in real-world emergencies? As the landscape of anaphylaxis treatment evolves, pharmacists will play a critical role in evaluating emerging therapies and translating new options into safe, practical patient care.

Overview of Anaphylaxis

Hypersensitivity reactions are immune-mediated responses that result in tissue injury and clinical symptoms. They are classified into four types (I-IV) based on their underlying immunologic mechanism and timing of presentation. The chart below outlines the key features and common examples of each type.

As a type I hypersensitivity reaction, anaphylaxis represents the most acute and potentially life-threatening immune response. The table below highlights common triggers and causes that pharmacists should be aware of.

Recognizing and responding to anaphylaxis is a critical skill for all healthcare personnel. Prompt anaphylaxis treatment should be considered when a patient presents with generalized symptoms such as hives, or more serious, potentially life-threatening signs including hypotension, respiratory distress, significant swelling of the lips or tongue, or involvement of more than one body system. Other common clinical manifestations of anaphylaxis include:

  • Respiratory—Sensation of throat closing, stridor (high-pitched sound while breathing), shortness of breath, wheezing, or cough
  • Gastrointestinal—Nausea or vomiting, diarrhea, abdominal pain
  • Cardiovascular—Dizziness or fainting, tachycardia, hypotension
  • Skin mucosal—Generalized hives, itching, swelling of lips, face or throat
  • Neurological—agitation, convulsions, acute change in mental status, sensation of impending doom

If a patient exhibits any of these signs, especially when multiple systems are involved, immediate recognition and intervention is essential. Prompt action can be lifesaving and prevents progression to severe or fatal outcomes. Here is what to do when anaphylaxis is suspected:

  1. Assess airway, breathing, and circulation (ABCs)
  2. Administer epinephrine immediately
  3. Call emergency medical services
  4. Place the patient in supine position

Current Epinephrine Options

When anaphylaxis occurs, epinephrine is the lifesaving first-line treatment, and timely administration is critical. The current FDA-approved epinephrine options are:

  • Neffy® nasal spray by ARS Pharma
  • EpiPen® / EpiPen Jr® or their generics
  • Auvi-Q® Auto-Injector
  • Authorized generic of Adrenaclick® by Amneal Pharmaceuticals
  • Generic of EpiPen® / EpiPen Jr® by Teva Pharmaceuticals
  • EpiPen® / EpiPen Jr® and authorized generics by Viatris (formerly Mylan)

Even with multiple options on the market, no form of epinephrine has been shown to be more or less effective than another. In practice, insurance coverage often determines which option a patient receives. Most auto-injectors and the nasal spray come in two packs to ensure a backup dose is available in case a second injection is needed or in case the first device malfunctions. The table below shows a comparison between the auto-injector and nasal spray version of epinephrine.

Despite the availability of multiple epinephrine options, there are several challenges to consider. Patients and caregivers may become confused when faced with different devices or administration instructions, and fear of needles can lead to hesitation or improper use. In fact, a study from the National Institute of Health found that EAIs are used incorrectly 35-45% of the time. Access and insurance coverage can also be limiting factors, particularly for nasal spray options, which are less widely covered.

While epinephrine can be lifesaving, it is important for patients and healthcare providers to be aware of potential side effects and what to expect after administration. Side effects include:

  • Tachycardia
  • Arrhythmias
  • Palpitations
  • Hypertension
  • Headache
  • Tremor, weakness
  • Pallor, sweating
  • Nausea and vomiting
  • Nervousness and anxiety
  • Pain, redness at the injection site
  • Tissue necrosis (if extravasated)

What is Sublingual Epinephrine?

For decades, epinephrine has been the frontline defense against anaphylaxis, now it is getting a needle-free upgrade. A new oral form of epinephrine is currently in clinical development, representing the first and only oral delivery option for Type I allergic reactions, including anaphylaxis. This innovative formulation contains a prodrug of epinephrine that is designed to be portable while achieving rapid absorption through sublingual administration.

The oral epinephrine is about the size of a postage stamp and weighs less than an ounce. Its packaging is even thinner and smaller than the average credit card, making it easy to carry in a pocket. It can also withstand weather conditions like rain or sunlight. 

Anaphylm offers several advantages to patients and providers including:

With oral epinephrine on the horizon, the future of anaphylaxis management could be more convenient, safer and patient-friendly than ever before.

Challenges and Considerations for Anaphylm

While oral epinephrine offers exciting benefits, there are some current limitations to be aware of. On January 30, 2026, the FDA issues Anaphylm a Complete Response Letter, meaning the product was not approved in its current form. The agency raised concerns about usability, including trouble opening the pouch and correctly placing the film under the tongue. Importantly, these issues were related to the packaging and administration, rather than the drug’s safety or efficacy. 

The main issues involve practicality during emergency situations and the need for additional pharmacokinetic data. The company developing the product believes these concerns can be resolved quickly, with plans to resubmit as early as summer 2026. The FDA is requesting further information on packaging, labeling, and pharmacokinetics, and details on insurance coverage remain uncertain at this time. 

Despite these hurdles, oral epinephrine remains a promising innovation that could significantly improve the accessibility and ease of anaphylaxis treatment once these issues are addressed.

The Final Consensus of Anaphylm for Patients

Anaphylaxis remains one of the most urgent and high-stakes emergencies pharmacists may encounter, and rapid access to epinephrine continues to be the mainstay of treatment. While current auto-injectors and nasal formulations are effective, challenges such as device confusion, administration errors, and access barriers still exist. Emerging innovations like oral epinephrine have the potential to reshape the future of anaphylaxis management by improving portability, ease of use, and patient confidence. As the treatment landscape continues to evolve, pharmacists will remain at the forefront to educate patients, navigate coverage barriers, and ensure that when seconds matter the most, lifesaving therapy is ready and within reach. 

APPE Student, Hailey Montour

References

Allergy & Asthma Network. Anaphylaxis Statistics. Accessed February 26, 2026. https://allergyasthmanetwork.org/anaphylaxis/anaphylaxis-statistics/ 

Aquestive Therapeutics. Anaphylm®. Accessed February 26, 2026. https://aquestive.com/anaphylm/ 

Aquestive Therapeutics. Sublingual epinephrine (Anaphylm®) provides consistent pharmacokinetics in both adult and pediatric subjects. Accessed February 26, 2026. https://www.aquestivedata.com/pdfs/sublingual_epinephrine_anaphylm_provides_consistent_pharmacokinetics_in_both_adult_and_pediatric_subjects.pdf

Centers for Disease Control and Prevention (CDC). Recognizing and Responding to Anaphylaxis. Accessed February 26, 2026. https://www.cdc.gov/vaccines/covid-19/downloads/recognizing-responding-to-anaphylaxis-508.pdf 

Food Allergy Research & Education (FARE). Epinephrine Options and Training. Accessed February 26, 2026. https://www.foodallergy.org/resources/epinephrine-options-and-training 

Food Allergy Research & Education (FARE). What Epinephrine Option Is Best for You? Accessed February 26, 2026. https://aafa.org/wp-content/uploads/2026/02/what-epinephrine-option-is-best-for-you.pdf 

Kraus CN, Wargacki S, Golden D, Lieberman J, Greenhawt M, Camargo CA Jr. Integrated phase I pharmacokinetics and pharmacodynamics of epinephrine administered through sublingual film, autoinjector, or manual injection. Ann Allergy Asthma Immunol. 2025;134(5):580-586. doi:10.1016/j.anai.2025.01.006

Ziyar A, Kwon J, Li A, Naderi A, Jean T. Improving epinephrine autoinjector usability and carriage frequency among patients at risk of anaphylaxis: a quality improvement initiative. BMJ Open Qual. 2022;11(3):e001742. doi:10.1136/bmjoq-2021-001742

Anaphylm (Dibutepinephrine): A New Frontier in Anaphylaxis Management Read More »

error: Content is protected !!
Popup Form

Want to get a free MPJE® or NAPLEX® cheat sheet? Subscribe to our email list!

By subscribing to this email list, you agree to our Privacy Policy and consent to receive emails from us.

MPJE® is a registered trademark of the National Association of Boards of Pharmacy. RxPharmacist®, LLC. and its services are neither affiliated with nor endorsed by the NABP®. None of the trademark holders is affiliated with, and does not endorse RxPharmacist’s product/site.

0